Over the past three decades, the treatment of both primary and secondary liver malignancies has been improved by the development and optimization of multiple m…

Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT05053555

Phase 2

A Single Arm Phase 2 Study of Y-90 SIRT in Combination With Durvalumab (MEDI 4736) and Gemcitabine/Cisplatin in Locally Advanced, Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

This trial is designed to study a combination of interventions (chemotherapy, immunotherapy, and radiation) as a potential new treatment for bile duct cancer t…

Bile Duct CancerCholangiocarcinomaCholangiocarcinoma Non-resectable+2 more

~Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT05655949